Mankind Pharma, India’s fourth-largest pharmaceutical company, has announced a strategic collaboration with OpenAI to institutionalize artificial intelligence (AI) across its value chain. As one of the first Indian pharmaceutical companies to fully integrate advanced AI into core operations, Mankind aims to accelerate innovation, enhance operational efficiency, and deliver greater value to customers, doctors, and the broader healthcare ecosystem.
Full-Scale AI Integration Across Operations
Under this collaboration, Mankind will integrate OpenAI Enterprise, including ChatGPT Enterprise, into multiple business functions such as:
- Field Force Enablement – Empowering on-ground teams with real-time data and insights
- Digital Marketing – Driving targeted, multilingual campaigns at scale
- Research & Development (R&D) – Accelerating scientific discovery and clinical intelligence
- Manufacturing – Detecting anomalies early and improving process reliability
- Medical Affairs – Delivering fast, compliant, and precise communication
This move reflects Mankind Pharma’s commitment to becoming a future-ready, intelligent enterprise capable of turning large volumes of data into actionable insights, streamlining operations, and ensuring compliance across complex processes.
Leadership Perspective
Arjun Juneja, Chief Operating Officer of Mankind Pharma Ltd., emphasized the transformative impact of this collaboration:
“At Mankind Pharma, we see working with OpenAI as a pivotal step in building the pharma organization of the future. By integrating advanced AI into our core operations, we are enabling our teams to move faster, work smarter, and unlock insights that create real-world impact – whether in field force effectiveness, supply chain agility, or R&D acceleration. This is not just about automation; it’s about building a more responsive, intelligent, and future-ready enterprise. We are excited to lead this shift in Indian pharma and set new benchmarks for technology-driven value creation.”
Key Benefits of AI Integration
Mankind Pharma’s AI-powered transformation will focus on several high-impact areas:
- Smarter Decision-Making – GPT-powered dashboards will provide real-time insights for R&D, supply chain, and commercial operations.
- Faster, Compliant Communication – Automated, multilingual messaging will ensure speed, accuracy, and regulatory compliance when engaging with healthcare professionals and patients.
- Function-Specific AI Agents – Dedicated agents for Sales, Marketing, R&D, and HR will streamline workflows and drive productivity.
- Advanced Clinical Intelligence – AI will support literature reviews and generate real-time insights from clinical and genomic data, accelerating scientific breakthroughs.
- Manufacturing Excellence – AI will analyze batch records and sensor data to detect anomalies early and recommend corrective actions, reducing risks and improving reliability.
Proven Impact Since July 2025
Since July 2025, Mankind Pharma has successfully deployed a wide range of customized GPTs across its workforce. These tools have:
- Enhanced Sales & Marketing effectiveness
- Improved multilingual communication with stakeholders
- Strengthened demand planning and procurement
- Enabled real-time measurement of field force performance
- Streamlined clinical insights and manufacturing processes
This has allowed leadership to focus on growth and innovation, creating a more agile and data-driven organization.
Unlocking Custom GPT Potential
Custom GPTs enable Mankind’s teams to create AI assistants tailored to their needs, defining personality, tone, and specialized knowledge bases while integrating proprietary workflows. This flexibility allows the company to build industry-specific AI solutions without requiring deep technical expertise.
OpenAI’s Perspective
Oliver Jay, Managing Director, International at OpenAI, highlighted the significance of this adoption:
“Mankind Pharma’s company-wide adoption of ChatGPT Enterprise demonstrates how AI can play a practical role in regulated industries like pharmaceuticals. By integrating AI into research, operations, and medical communications, Mankind is taking meaningful steps to improve efficiency and foster innovation. We are excited to support them in applying AI responsibly and safely to create value within their organization and across the healthcare ecosystem.”